MELILLO, ROSA MARINA
MELILLO, ROSA MARINA
DIPARTIMENTO DI MEDICINA MOLECOLARE E BIOTECNOLOGIE MEDICHE
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2).
2003 Carlomagno, F; Vitagliano, D; Guida, T; Basolo, F; Castellone, Md; Melillo, ROSA MARINA; Fusco, Alfredo; Santoro, Massimo
The docking protein FRS2 links RET and its oncogenic forms with the RAS/MAPK cascade.
2001 Melillo, ROSA MARINA; Santoro, Massimo; S. H., Ong; M., Billaud; Fusco, Alfredo; J., Schlessinger; I., Lax
Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes.
2003 Castellone, Md; Cirafici, Am; DE VITA, G; DE FALCO, V; Malorni, L; Tallini, G; Fagin, Ja; Fusco, Alfredo; Melillo, ROSA MARINA; Santoro, Massimo
Genetic Alterations in differentiated thyroid cancer:what can be expected for gene expression profiling of thyroid carcinomas
2003 Santoro, Massimo; Melillo, ROSA MARINA; Carlomagno, Francesca; Castellone, MARIA DOMENICA; Vitagliano, Donata; Guida, Teresa; Vecchio, Giancarlo; Fusco, Alfredo
The neuron-specific Rai (ShcC) adaptor protein inhibits apoptosis by coupling Ret to the phosphatidylinositol 3-kinase/Akt signaling pathway.
2002 Pelicci, G; Troglio, F; Bodini, A; Melillo, ROSA MARINA; Pettirossi, V; Coda, L; DE GIUSEPPE, A; Santoro, Massimo; Pelicci, Pg
The Insulin Receptor Substrate (IRS)-1 recruits Phosphatidylinositol 3-Kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret.
2001 Melillo, ROSA MARINA; Carlomagno, Francesca; DE VITA, Gabriella; Formisano, Pietro; Vecchio, Giancarlo; Fusco, Alfredo; Billaud, M.; Santoro, Massimo
RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho.
2001 Barone, MARIA VITTORIA; Sepe, L; Melillo, ROSA MARINA; Mineo, A; Santelli, G; Monaco, C; Castellone, Md; Tramontano, Donatella; Fusco, Alfredo; Santoro, Massimo
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2)
2003 Carlomagno, Francesca; Vitagliano, D; Guida, T; Basolo, F; Castellone, Md; Melillo, ROSA MARINA; Fusco, Alfredo; Santoro, Massimo
Molecular heterogeneity of RET loss of function in Hirschsprung's disease
1996 Carlomagno, Francesca; DE VITA, Gabriella; Berlingieri, Mt; DE FRANCISCIS, V; Melillo, ROSA MARINA; Colantuoni, V; Kraus, Mh; DI FIORE, Pp; Fusco, Alfredo; Santoro, M.
Cloning and characterization of H4 (D10S170), a gene involved in RET rearrangements in vivo.
1994 Grieco, M.; Cerrato, A.; Santoro, Massimo; Fusco, Alfredo; Melillo, ROSA MARINA; Vecchio, Giancarlo
PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.
1990 Grieco, M.; Santoro, Massimo; Berlingieri, M. T.; Melillo, ROSA MARINA; Donghi, R.; Bongarzone, I.; Pierotti, M. A.; Della Porta, G.; Fusco, Alfredo; Vecchio, Giancarlo
RET ONCOGENE ACTIVATION IN HUMAN THYROID NEOPLASMS IS RESTRICTED TO THE PAPILLARY CANCER SUBTYPE
1992 Santoro, Massimo; Carlomagno, Francesca; Hay, I. D.; Herrmann, M. A.; Grieco, M.; Melillo, ROSA MARINA; Pierotti, M. A.; Bongarzone, I.; DELLA PORTA, G.; Berger, N.; Peix, J. L.; Paulin, C.; Fabien, N.; Vecchio, Giancarlo; Jenkins, R. B.; Fusco, Alfredo
The TRK and RET tyrosine kinase oncogenes cooperate with ras in the neoplastic transformation of a rat thyroid epithelial cell line.
1993 Santoro, Massimo; Melillo, ROSA MARINA; Grieco, M.; Berlingieri, M. T.; Vecchio, Giancarlo; Fusco, Alfredo
Molecular mechanisms of RET activation in human cancer.
2002 Santoro, Massimo; Melillo, ROSA MARINA; Carlomagno, Francesca; Fusco, Alfredo; Vecchio, Giancarlo
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma
2002 F., Basolo; R., Giannini; C., Monaco; Melillo, ROSA MARINA; Carlomagno, Francesca; M., Pancrazi; G., Salvatore; G., Chiappetta; F., Pacini; R., Elisei; P., Miccoli; A., Pinchera; Fusco, Alfredo; Santoro, Massimo
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype.
1997 Carlomagno, Francesca; G., Salvatore; A. M., Cirafici; DE VITA, Gabriella; Melillo, ROSA MARINA; V. d., Franciscis; M., Billaud; Fusco, Alfredo; Santoro, Massimo
Molecular mechanisms of RET activation in human neoplasia.
1999 Santoro, Massimo; Carlomagno, Francesca; Melillo, ROSA MARINA; M., Billaud; Vecchio, Giancarlo; Fusco, Alfredo
Molecular defects in thyroid carcinomas: role of the RET oncogene in thyroid neoplastic transformation.
1995 Santoro, Massimo; M., Grieco; Melillo, ROSA MARINA; Fusco, Alfredo; Vecchio, Giancarlo
Helicobacter pylori Hp(2-20) promotes gastric mucosal healing and interacts with formyl-peptide receptors.
2010 DE PAULIS, Amato; Prevete, Nella; Rossi, F. W.; Rivellese, F.; Salerno, F.; Liccardo, B.; Melillo, ROSA MARINA; Romano, M.; Marone, G.
The Formyl Peptide Receptor 1 Exerts a Tumor Suppressor Role in Human Gastric Cancer by Suppressing Angiogenesis
2014 Prevete, Nella; Liotti, Federica; Visciano, Carla; DE PAULIS, Amato; Melillo, ROSA MARINA; Marone, Gianni
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2). | 1.1 Articolo in rivista | 2003 | Carlomagno, F; Vitagliano, D; Guida, T; Basolo, F; Castellone, Md; Melillo, ROSA MARINA; Fusco, Alfredo; Santoro, Massimo | |
| The docking protein FRS2 links RET and its oncogenic forms with the RAS/MAPK cascade. | 1.1 Articolo in rivista | 2001 | Melillo, ROSA MARINA; Santoro, Massimo; S. H., Ong; M., Billaud; Fusco, Alfredo; J., Schlessinger; I., Lax | |
| Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes. | 1.1 Articolo in rivista | 2003 | Castellone, Md; Cirafici, Am; DE VITA, G; DE FALCO, V; Malorni, L; Tallini, G; Fagin, Ja; Fusco, Alfredo; Melillo, ROSA MARINA; Santoro, Massimo | |
| Genetic Alterations in differentiated thyroid cancer:what can be expected for gene expression profiling of thyroid carcinomas | 1.1 Articolo in rivista | 2003 | Santoro, Massimo; Melillo, ROSA MARINA; Carlomagno, Francesca; Castellone, MARIA DOMENICA; Vitagliano, Donata; Guida, Teresa; Vecchio, Giancarlo; Fusco, Alfredo | |
| The neuron-specific Rai (ShcC) adaptor protein inhibits apoptosis by coupling Ret to the phosphatidylinositol 3-kinase/Akt signaling pathway. | 1.1 Articolo in rivista | 2002 | Pelicci, G; Troglio, F; Bodini, A; Melillo, ROSA MARINA; Pettirossi, V; Coda, L; DE GIUSEPPE, A; Santoro, Massimo; Pelicci, Pg | |
| The Insulin Receptor Substrate (IRS)-1 recruits Phosphatidylinositol 3-Kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret. | 1.1 Articolo in rivista | 2001 | Melillo, ROSA MARINA; Carlomagno, Francesca; DE VITA, Gabriella; Formisano, Pietro; Vecchio, Giancarlo; Fusco, Alfredo; Billaud, M.; Santoro, Massimo | |
| RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho. | 1.1 Articolo in rivista | 2001 | Barone, MARIA VITTORIA; Sepe, L; Melillo, ROSA MARINA; Mineo, A; Santelli, G; Monaco, C; Castellone, Md; Tramontano, Donatella; Fusco, Alfredo; Santoro, Massimo | |
| Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2) | 1.1 Articolo in rivista | 2003 | Carlomagno, Francesca; Vitagliano, D; Guida, T; Basolo, F; Castellone, Md; Melillo, ROSA MARINA; Fusco, Alfredo; Santoro, Massimo | |
| Molecular heterogeneity of RET loss of function in Hirschsprung's disease | 1.1 Articolo in rivista | 1996 | Carlomagno, Francesca; DE VITA, Gabriella; Berlingieri, Mt; DE FRANCISCIS, V; Melillo, ROSA MARINA; Colantuoni, V; Kraus, Mh; DI FIORE, Pp; Fusco, Alfredo; Santoro, M. | |
| Cloning and characterization of H4 (D10S170), a gene involved in RET rearrangements in vivo. | 1.1 Articolo in rivista | 1994 | Grieco, M.; Cerrato, A.; Santoro, Massimo; Fusco, Alfredo; Melillo, ROSA MARINA; Vecchio, Giancarlo | |
| PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. | 1.1 Articolo in rivista | 1990 | Grieco, M.; Santoro, Massimo; Berlingieri, M. T.; Melillo, ROSA MARINA; Donghi, R.; Bongarzone, I.; Pierotti, M. A.; Della Porta, G.; Fusco, Alfredo; Vecchio, Giancarlo | |
| RET ONCOGENE ACTIVATION IN HUMAN THYROID NEOPLASMS IS RESTRICTED TO THE PAPILLARY CANCER SUBTYPE | 1.1 Articolo in rivista | 1992 | Santoro, Massimo; Carlomagno, Francesca; Hay, I. D.; Herrmann, M. A.; Grieco, M.; Melillo, ROSA MARINA; Pierotti, M. A.; Bongarzone, I.; DELLA PORTA, G.; Berger, N.; Peix, J. L.; Paulin, C.; Fabien, N.; Vecchio, Giancarlo; Jenkins, R. B.; Fusco, Alfredo | |
| The TRK and RET tyrosine kinase oncogenes cooperate with ras in the neoplastic transformation of a rat thyroid epithelial cell line. | 1.1 Articolo in rivista | 1993 | Santoro, Massimo; Melillo, ROSA MARINA; Grieco, M.; Berlingieri, M. T.; Vecchio, Giancarlo; Fusco, Alfredo | |
| Molecular mechanisms of RET activation in human cancer. | 1.1 Articolo in rivista | 2002 | Santoro, Massimo; Melillo, ROSA MARINA; Carlomagno, Francesca; Fusco, Alfredo; Vecchio, Giancarlo | |
| Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma | 1.1 Articolo in rivista | 2002 | F., Basolo; R., Giannini; C., Monaco; Melillo, ROSA MARINA; Carlomagno, Francesca; M., Pancrazi; G., Salvatore; G., Chiappetta; F., Pacini; R., Elisei; P., Miccoli; A., Pinchera; Fusco, Alfredo; Santoro, Massimo | |
| The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype. | 1.1 Articolo in rivista | 1997 | Carlomagno, Francesca; G., Salvatore; A. M., Cirafici; DE VITA, Gabriella; Melillo, ROSA MARINA; V. d., Franciscis; M., Billaud; Fusco, Alfredo; Santoro, Massimo | |
| Molecular mechanisms of RET activation in human neoplasia. | 1.1 Articolo in rivista | 1999 | Santoro, Massimo; Carlomagno, Francesca; Melillo, ROSA MARINA; M., Billaud; Vecchio, Giancarlo; Fusco, Alfredo | |
| Molecular defects in thyroid carcinomas: role of the RET oncogene in thyroid neoplastic transformation. | 1.1 Articolo in rivista | 1995 | Santoro, Massimo; M., Grieco; Melillo, ROSA MARINA; Fusco, Alfredo; Vecchio, Giancarlo | |
| Helicobacter pylori Hp(2-20) promotes gastric mucosal healing and interacts with formyl-peptide receptors. | 8.02 Comunicazioni a Convegni o Seminari | 2010 | DE PAULIS, Amato; Prevete, Nella; Rossi, F. W.; Rivellese, F.; Salerno, F.; Liccardo, B.; Melillo, ROSA MARINA; Romano, M.; Marone, G. | |
| The Formyl Peptide Receptor 1 Exerts a Tumor Suppressor Role in Human Gastric Cancer by Suppressing Angiogenesis | 4.2 Abstract in Atti di convegno | 2014 | Prevete, Nella; Liotti, Federica; Visciano, Carla; DE PAULIS, Amato; Melillo, ROSA MARINA; Marone, Gianni |